At this time, I'd like to welcome everyone to the Paysign, Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call. After the speakers’ remarks, there will be a question-and-answer session.

Adjusted EBITDA Guidance (2025): Expected to be $12.5 million to $13.5 million. PaySign Inc (NASDAQ:PAYS) reported a 23.5% increase in revenue for 2024, reaching $58.4 million. The patient ...

PaySign Inc (PAYS) reports a 23.5% revenue increase and strategic acquisition to bolster future growth despite challenges in the plasma business.